ClinicalTrials.govpublic full text
Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer
metastatic colorectal cancer, vemurafenib, panitumumab, v600e braf mutation, colon, 12-221, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1047234
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.